|
POLR2D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.673400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.069150E-01 |
| Normal-vs-Stage2 |
6.325600E-01 |
| Normal-vs-Stage3 |
1.261420E-01 |
| Normal-vs-Stage4 |
1.530360E-01 |
| Stage1-vs-Stage2 |
1.723400E-01 |
| Stage1-vs-Stage3 |
6.762400E-03 |
| Stage1-vs-Stage4 |
8.470200E-02 |
| Stage2-vs-Stage3 |
4.294000E-01 |
| Stage2-vs-Stage4 |
2.304200E-01 |
| Stage3-vs-Stage4 |
3.173200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.362600E-01 |
| Normal-vs-AfricanAmerican |
8.051400E-01 |
| Normal-vs-Asian |
3.051800E-01 |
| Caucasian-vs-AfricanAmerican |
6.863000E-01 |
| Caucasian-vs-Asian |
1.967240E-01 |
| AfricanAmerican-vs-Asian |
2.680400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.204390E-01 |
| Normal-vs-Female |
6.769700E-04 |
| Male-vs-Female |
1.66430000003714E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.889800E-01 |
| Normal-vs-Extreme_Weight |
2.506000E-02 |
| Normal-vs-Obese |
1.843410E-01 |
| Normal-vs-Extreme_Obese |
5.524000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.991630E-01 |
| Normal_Weight-vs-Obese |
1.723390E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.596400E-01 |
| Extreme_Weight-vs-Obese |
3.801900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.822200E-01 |
| Obese-vs-Extreme_Obese |
2.892200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.992400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.786170E-01 |
| Normal-vs-Age(61-80Yrs) |
1.282380E-01 |
| Normal-vs-Age(81-100Yrs) |
2.189400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.602000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.837810E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.072100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.535000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.962300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.213700E-02 |
| Normal-VS-Type2 PRCC |
7.358200E-01 |
| Normal-VS-KIRP CIMP |
2.721500E-03 |
| Normal-VS-Unclassified PRCC |
2.195800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.183430E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.26659999050349E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
3.454500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.356340E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.804200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.196500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.248000E-01 |
| Normal-vs-N1 |
5.438800E-03 |
| Normal-vs-N2 |
1.884770E-01 |
| N0-vs-N1 |
1.841140E-03 |
| N0-vs-N2 |
1.133670E-02 |
| N1-vs-N2 |
9.381800E-01 |
|
|
